• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Unknown·INNV
Held by 2 Gurus
Share

InnovAge Holding Corp. Stocks

$ 9.32Last Updated 23.06.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 1.27B

$ 9.32
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Manager
Fund
Portfolio Weight (%)
Change
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Sign up, to see portfolios that hold this stock
Sign up, to see portfolios that hold this stock

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

InnovAge Holding Corp. specializes in providing a comprehensive suite of medical and supportive services designed to empower older adults to maintain independence within their homes and communities. Its operational framework is based on the Program of All-Inclusive Care for the Elderly (PACE) model. The company's diverse service offerings encompass both in-home assistance (including skilled, unskilled, and personal care) and on-site center-based provisions. These center services span primary medical care, various therapies (physical, occupational, speech), dental services, mental health support, nutritious meals, and engaging activities. Additionally, InnovAge facilitates transportation to PACE centers and external medical appointments, alongside comprehensive care management. The company currently supports approximately 6,850 PACE participants across the United States, operating 18 dedicated PACE centers in key states including Colorado, California, New Mexico, Pennsylvania, and Virginia. Established in 2007, the company was formerly known as TCO Group Holdings, Inc. before rebranding as InnovAge Holding Corp. in January 2021. InnovAge maintains its corporate headquarters in Denver, Colorado.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA, overvalued on P/F

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of INNV is 7.0 and suggests 25% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.06.2026 23:34

Deal in the Rare Earth Metals Market: U.S. Mid-Cap Company Aims to Compete with China

24.06.2026 23:10

OpenAI and Broadcom have unveiled a new chip that will cut the cost of running AI in half

24.06.2026 22:40

S&P Raised the Credit Ratings of Four Freedom Subsidiaries with a Stable Outlook

24.06.2026 22:19

Shares of Nvidia's competitor plummeted 17% following the earnings report. What spooked investors?

24.06.2026 20:36

Fast-food chain Wendy’s soars 40% on meme-stock hype

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026